Business Standard
Home / India News / Lupin launches Desoximetasone Cream in United States

Lupin launches Desoximetasone Cream in United States

Image

Capital Market
Last Updated : Jun 22 2017 | 4:47 PM IST

In United States

Lupin announced the launch of its Desoximetasone Cream USP, 0.05% and Desoximetasone Cream USP, 0.25% having received an approval from the USFDA earlier.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Also Read

Drugmaker Lupin posts strong Q3; warns competition to drag next year

Drugmaker Lupin posts strong Q3; warns competition to drag next year

Lupin warns of more pricing pressure as fourth-quarter profit halves

Lupin warns of more pricing pressure as fourth-quarter profit halves

Lupin posts better-than-expected Q3 profit as US sales rise

Lupin posts better-than-expected Q3 profit as US sales rise

Drugmaker Lupin's profit halves as U.S. sales slump

Drugmaker Lupin's profit halves as U.S. sales slump

Lupin launches Bupropion Hydrochloride Extended Release Tablets

Lupin launches Bupropion Hydrochloride Extended Release Tablets

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jun 22 2017 | 4:23 PM IST

Explore News

Market LIVEMarket TodaySai Life Sciences IPOToss The Coin IPO AllotmentLatest News LIVEStocks To Watch TodayProcess to withdraw PF by ATMGold-Silver Price TodayIPO NewsBusiness Standard at 50
HOT STOCKS
TOP SECTIONS
KEY EVENTS
Copyrights © 2024 Business Standard Private Ltd. All rights reserved
LinkedIN Icon